Beta Drugs Limited — ≥1% Shareholders
Every non-promoter shareholder owning 1% or more of Beta Drugs Limited, parsed from the latest quarterly Shareholding Pattern filing. Curated holders link to a tracked profile; mystery holders are flagged.
1 curated
6 mystery
Quarter: Mar 2026
Institutional intelligence for Beta Drugs Limited
Cross-view mutual fund activity and super-investor shareholding · Mar 2026 SHP.
Tracked super investors holding ≥1%
| Holder | Type | % of company | Shares | Value (₹ Cr) |
|---|---|---|---|---|
| Neeraj Batra | individual | 63.86% | 64,73,631 | ₹769.9 Cr |
| Suryavanshi Commotrade Private Limited | dii | 6.71% | 6,80,026 | ₹80.9 Cr |
| Ashish Kacholia | individual | 5.76% | 5,83,800 | ₹69.4 Cr |
| Airavat Capital Trust - Airavat Capital Trust Ii | dii | 1.68% | 1,69,997 | ₹20.2 Cr |
| Bsas Infotech Limited . | dii | 1.31% | 1,32,762 | ₹15.8 Cr |
| Onkar Singh | individual | 1.06% | 1,07,205 | ₹12.8 Cr |
| Surendra Kumar Jain | individual | 1.02% | 1,03,110 | ₹12.3 Cr |
Shareholding data sourced from NSE/BSE regulatory filings. Not investment advice. See our disclaimer and methodology.